Ixmyelocel-T, mesenchymal stem cells and myocytes for critical limb ischemia
Ixmyelocel-T is a mixture of CD90+ mesenchymal stem cells and myocytes, specifically expanded, by an automated cell-processing system, from autologous bone marrow. Other cell types from the bone marrow are partially depleted. Ixmyelocel-T treatment is safe and improves time to treatment failure in critical limb ischemia patients.
Read More
Product Information for
Ixmyelocel-T, mesenchymal stem cells and myocytes for critical limb ischemia
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access